Brief: Knight And TherapeuticsMD Announce Filing Of New Drug Submission For Joyesta In Canada
Oct 30 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT AND THERAPEUTICSMD ANNOUNCE FILING OF NEW DRUG
SUBMISSION
FOR JOYESTA™ IN CANADA
* KNIGHT THERAPEUTICS INC - NEW DRUG SUBMISSION (NDS) FOR
JOYESTA
HAS BEEN ACCEPTED FOR REVIEW BY HEALTH CANADA.
Source text for Eikon: ID:nGNXBHPXX
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil